Literature DB >> 24119849

Vitamin D receptor signaling in renal and cardiovascular protection.

Yan Chun Li1.   

Abstract

The high prevalence of vitamin D deficiency in patients with chronic kidney disease is believed to be an important risk factor for the cardiorenal syndrome commonly seen in this patient population. African Americans suffer a disproportionally high incidence of renal and cardiovascular disease with poor disease outcome, which may be partly attributed to their low vitamin D status in part owing to low subcutaneous photoproduction of vitamin D. Mounting evidence from animal and clinical studies has shown beneficial effects of vitamin D therapy on the renal and cardiovascular systems, and the underlying renoprotective and cardioprotective mechanisms of vitamin D receptor (VDR)-mediated signaling are under intense investigation. In this article, our most recent understanding of the renal protective mechanism of the podocyte VDR signaling against diabetic nephropathy and the anti-atherosclerotic role of macrophage VDR signaling in the regulation of atherosclerosis is reviewed.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Vitamin D deficiency; atherosclerosis; diabetic nephropathy; macrophage; podocyte; renin-angiotensin system

Mesh:

Substances:

Year:  2013        PMID: 24119849      PMCID: PMC3796773          DOI: 10.1016/j.semnephrol.2013.07.005

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  103 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor.

Authors:  A R Brasier; M Jamaluddin; Y Han; C Patterson; M S Runge
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.

Authors:  S Keidar; R Heinrich; M Kaplan; T Hayek; M Aviram
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

4.  High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor.

Authors:  Evangelia Tsiani; Poli Lekas; I George Fantus; John Dlugosz; Catharine Whiteside
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-01       Impact factor: 4.310

5.  Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice.

Authors:  C A Reardon; L Blachowicz; T White; V Cabana; Y Wang; J Lukens; J Bluestone; G S Getz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

Review 6.  Leukocyte recruitment to atherosclerotic lesions, a complex web of dynamic cellular and molecular interactions.

Authors:  Einar E Eriksson
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2003-12

7.  Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.

Authors:  Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Masaaki Inaba; Shinya Fukumoto; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

8.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

Authors:  Ming Teng; Myles Wolf; Edmund Lowrie; Norma Ofsthun; J Michael Lazarus; Ravi Thadhani
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

Review 9.  The intrarenal renin-angiotensin system and diabetic nephropathy.

Authors:  Robert M Carey; Helmy M Siragy
Journal:  Trends Endocrinol Metab       Date:  2003-08       Impact factor: 12.015

10.  1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.

Authors:  Alexander Kuhlmann; Christian S Haas; Marie-Luise Gross; Udo Reulbach; Marc Holzinger; Ute Schwarz; Eberhard Ritz; Kerstin Amann
Journal:  Am J Physiol Renal Physiol       Date:  2003-11-04
View more
  8 in total

1.  Total synthesis of biologically active 20S-hydroxyvitamin D3.

Authors:  Qinghui Wang; Zongtao Lin; Tae-Kang Kim; Andrzej T Slominski; Duane D Miller; Wei Li
Journal:  Steroids       Date:  2015-10-01       Impact factor: 2.668

Review 2.  Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.

Authors:  Tianxin Yang; Chuanming Xu
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

3.  [Association of serum vitamin D level with severity and treatment in children with Henoch-Schönlein purpura].

Authors:  Li Fan; Heng Liu; Yu-Chuan Wang; Li Chen; Jing-Jing Zhou; Yu-Xia Cui
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

Review 4.  Vitamin D deficiency in the pathogenesis of hypertension: still an unsettled question.

Authors:  Stephen G Rostand
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

5.  Antifibrotic vitamin D analogs.

Authors:  Joseph V Bonventre
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

6.  Vitamin D Levels Decline with Rising Number of Cardiometabolic Risk Factors in Healthy Adults: Association with Adipokines, Inflammation, Oxidative Stress and Advanced Glycation Markers.

Authors:  Zora Krivošíková; Martin Gajdoš; Katarína Šebeková
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 7.  The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy.

Authors:  Min Lei; Zhangsuo Liu; Jia Guo
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

8.  Hepatocyte gene expression and DNA methylation as ancestry-dependent mechanisms in African Americans.

Authors:  C S Park; T De; Y Xu; Y Zhong; E Smithberger; C Alarcon; E R Gamazon; M A Perera
Journal:  NPJ Genom Med       Date:  2019-11-25       Impact factor: 8.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.